pan-KRAS molecular glue therapy(Eilean Therapeutics LLC)

N/A

Report date: 2025/10/30 15:42:04
NME

Base Information

Drug Namepan-KRAS molecular glue therapy(Eilean Therapeutics LLC)
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A